Literature DB >> 27826779

Single-incision retroperitoneoscopic adrenalectomy: a North American experience.

Shonan Sho1, Michael W Yeh2, Ning Li3, Masha J Livhits2.   

Abstract

BACKGROUND: Endoscopic adrenalectomy is currently performed using multiple ports placed either transabdominally or retroperitoneally. We report our initial experience with single-incision retroperitoneoscopic adrenalectomy (SIRA).
METHODS: A prospective database of patients undergoing adrenalectomy from December 2013 through March 2016 was analyzed. We adopted conventional retroperitoneoscopic adrenalectomy (CORA) in December 2013 and transitioned to SIRA in March 2015. SIRA was performed using three trocars placed through a single 2-cm incision below the 12th rib. Clinical characteristics and outcomes were compared between patients undergoing SIRA and CORA.
RESULTS: One hundred and five adrenalectomies were performed in 102 patients: 34 laparoscopic transperitoneal, 24 CORA, 37 SIRA and 7 open. The SIRA and CORA groups were similar with respect to clinical characteristics (SIRA vs. CORA: mean BMI 27.0 vs. 28.8 kg/m2, maximum BMI 38.9 vs. 44.3 kg/m2; mean nodule size 3.2 vs. 3.2 cm, maximum nodule size 8.0 vs. 6.0 cm). One patient undergoing SIRA required placement of an additional 5-mm port because of extensive adhesions. No patients who underwent SIRA or CORA required conversion to open adrenalectomy. There were no deaths, and blood loss remained <10 mL for all cases. Operative length was similar between SIRA and CORA (105 vs. 92 min, P = 0.26). In multivariable linear regression analysis, nodule size > 5 cm (effect = 1.75, P < 0.001) and pheochromocytoma (effect = 1.30, P = 0.05) were significant predictors of increased operative length for SIRA. BMI and laterality (right vs. left) did not affect operative length. Rates of postoperative temporary abdominal wall relaxation, length of stay and postoperative pain medication use were similar between the two groups.
CONCLUSIONS: SIRA is safe and feasible to implement as a refinement of CORA and may be applied to technically challenging cases involving obese patients or large nodules. The use of three ports allows for two-handed dissection, which may shorten the learning curve for many surgeons.

Entities:  

Keywords:  Adrenalectomy; Retroperitoneoscopic adrenalectomy; Single-incision laparoscopic surgery

Mesh:

Year:  2016        PMID: 27826779     DOI: 10.1007/s00464-016-5325-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  15 in total

Review 1.  Laparoscopic adrenalectomy: new gold standard.

Authors:  C D Smith; C J Weber; J R Amerson
Journal:  World J Surg       Date:  1999-04       Impact factor: 3.352

2.  Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients.

Authors:  Martin K Walz; Piero F Alesina; Frank A Wenger; Anastasios Deligiannis; Eduard Szuczik; Stephan Petersenn; Andreas Ommer; Harald Groeben; Klaus Peitgen; Onno E Janssen; Thomas Philipp; Hartmut P H Neumann; Kurt W Schmid; Klaus Mann
Journal:  Surgery       Date:  2006-12       Impact factor: 3.982

3.  Laparoendoscopic Single-Site Retroperitoneoscopic Adrenalectomy Versus Conventional Retroperitoneoscopic Adrenalectomy in Obese Patients.

Authors:  Yang Wang; Yao He; Bin-Shen Li; Chao-Hui Wang; Zhi Chen; Miao-Long Lu; Zhi-Qiang Wen; Xiang Chen
Journal:  J Endourol       Date:  2015-11-13       Impact factor: 2.942

4.  A comparative study of multiport versus laparoendoscopic single-site adrenalectomy for benign adrenal tumors.

Authors:  Victor Chia-Hsiang Lin; Yao-Chou Tsai; Shiu-Dong Chung; Tin Chou Li; Chen-Hsun Ho; Fu-Shan Jaw; Huai-Ching Tai; Hong-Jeng Yu
Journal:  Surg Endosc       Date:  2011-11-15       Impact factor: 4.584

5.  Laparoendoscopic single-site (LESS) retroperitoneal adrenalectomy using a homemade single-access platform and standard laparoscopic instruments.

Authors:  Shiu-Dong Chung; Chao-Yuan Huang; Shuo-Meng Wang; Huai-Ching Tai; Yao-Chou Tsai; Shih-Chieh Chueh
Journal:  Surg Endosc       Date:  2010-09-17       Impact factor: 4.584

6.  Single access retroperitoneoscopic adrenalectomy (SARA)--one step beyond in endocrine surgery.

Authors:  Martin K Walz; Piero F Alesina
Journal:  Langenbecks Arch Surg       Date:  2008-09-11       Impact factor: 3.445

7.  Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment?

Authors:  Antonio Toniato; Isabella Merante Boschin; Giuseppe Opocher; Annamaria Guolo; Mariarosa Pelizzo; Franco Mantero
Journal:  Surgery       Date:  2007-06       Impact factor: 3.982

8.  Randomized clinical trial of posterior retroperitoneoscopic adrenalectomy versus lateral transperitoneal laparoscopic adrenalectomy with a 5-year follow-up.

Authors:  Marcin Barczyński; Aleksander Konturek; Wojciech Nowak
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

9.  Laparoendoscopic single-site retroperitoneoscopic adrenalectomy: a matched-pair comparison with the gold standard.

Authors:  Tao-ping Shi; Xu Zhang; Xin Ma; Hong-zhao Li; Jie Zhu; Bao-jun Wang; Jiang-ping Gao; Wei Cai; Juan Dong
Journal:  Surg Endosc       Date:  2010-12-18       Impact factor: 4.584

10.  Adrenalectomy by retroperitoneal laparoendoscopic single site surgery.

Authors:  Anibal Wood Branco; William Kondo; Luciano Carneiro Stunitz; Saturnino Ribeiro do Nascimento Neto; Carolina Cortese Ribeiro do Nascimento; Alcides José Branco Filho
Journal:  JSLS       Date:  2010 Oct-Dec       Impact factor: 2.172

View more
  2 in total

1.  Are Adrenal Lesions of 6 cm or More in Diameter a Contraindication to Laparoscopic Adrenalectomy? A Case-Control Study.

Authors:  Andrea Balla; Livia Palmieri; Francesca Meoli; Diletta Corallino; Monica Ortenzi; Pietro Ursi; Mario Guerrieri; Silvia Quaresima; Alessandro M Paganini
Journal:  World J Surg       Date:  2020-03       Impact factor: 3.352

Review 2.  Laparoendoscopic single-site adrenalectomy versus multi-port laparoendoscopic adrenalectomy: A systemic review and meta-analysis.

Authors:  Jeng-Cheng Wu; Po-Chien Wu; Yi-No Kang; Ting-En Tai
Journal:  Ann Med Surg (Lond)       Date:  2021-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.